Skip to main content

Table 6 Resistance rates(%) of Acinetobacter baumanii to antimicrobial agents

From: Bacterial resistance trends among intraoperative bone culture of chronic osteomyelitis in an affiliated hospital of South China for twelve years

Antimicrobial agent

2003–2004

(n = 0)

2005–2006

(n = 3)

2007–2008

(n = 6)

2009–2010

(n = 8)

2011–2012

(n = 17)

2013–2014

(n = 2)

Amikacin

–

66.7

66.7

50.0

64.7

100.0

Gentamicin

–

100.0

100.0

75.0

82.4

100.0

Piperacillin

–

100.0

66.7

75.0

88.2

100.0

Piperacillin/taazobactam

–

100.0

100.0

75.0

88.2

100.0

Cefazolin

–

100.0

100.0

100.0

100.0

100.0

Cefuroxime

–

100.0

100.0

100.0

100.0

–

Cefotaxime

–

100.0

80.0

75.0

82.4

100.0

Ceftazidime

–

100.0

60.0

50.0

76.5

50.0

Cefepime

–

100.0

100.0

50.0

70.6

50.0

Imipenem

–

33.3

16.7

50.0

64.7

100.0

Meropenem

–

100.0

0

80.0

75.0

100.0

Ciprofloxacin

–

100.0

83.3

62.5

70.6

100.0